Dietary lipids and cholesterol in the gastrointestinal tract

Dietary lipids and cholesterol in the gastrointestinal tract refer to the collection of fats, oils, and sterols consumed through the diet and their subsequent processing within the digestive system. This is not a single molecular target but a physiological pathway involving the emulsification of fats by bile, enzymatic breakdown by lipases, and transport across the intestinal epithelium (StatPearls, 2023). Key proteins involved in this process include pancreatic triacylglycerol lipase, which hydrolyzes triglycerides, and the Niemann-Pick C1-like 1 (NPC1L1) transporter, which facilitates cholesterol uptake (PubMed, PMID: 14739921). Pharmacological agents like Orlistat and Ezetimibe target these specific components to reduce the systemic absorption of lipids, thereby managing conditions such as obesity and hypercholesterolemia (NIH, 2022). By lowering the influx of dietary fats and cholesterol, these therapies help reduce plasma levels of low-density lipoprotein (LDL) cholesterol, a major risk factor for atherosclerosis and cardiovascular disease (AHA, 2021). However, the inhibition of these natural processes often results in gastrointestinal side effects, such as oily stools and potential deficiencies in fat-soluble vitamins (Mayo Clinic, 2023).

Other names

Intestinal lipid absorptionDietary fat absorptionCholesterol absorption processGastrointestinal lipid processing

Inhibition of gastrointestinal lipases (e.g., pancreatic lipase) to prevent the hydrolysis of triglycerides; inhibition of the NPC1L1 transporter to block the uptake of dietary and biliary cholesterol; and sequestration of bile acids to prevent their reabsorption, forcing the liver to use more cholesterol for bile acid synthesis.